Hinge Health, which provides wearable devices that reduce pain and improve musculoskeletal health, filed on Monday with the SEC for an initial public offering we estimate could raise up to $500 million.
Hinge Health leverages software to largely automate care for joint and muscle health. The company has designed its platform to address a broad spectrum of musculoskeletal (MSK) care, including acute injury, chronic pain, and post-surgical rehabilitation. To address the automation of care, Hinge has developed AI-powered motion tracking technology (TrueMotion), a proprietary FDA-cleared wearable device (Enso), and an AI-supported care team to deliver scalable and personalized MSK care.
The San Francisco, CA-based company was founded in 2012 and booked $390 million in revenue for the 12 months ended December 31, 2024. It plans to list on the NYSE under the symbol HNGE. Hinge Health filed confidentially on November 15, 2024. Morgan Stanley, Barclays, BofA Securities, Evercore ISI, RBC Capital Markets, Truist Securities, Stifel, William Blair, and Piper Sandler are the joint bookrunners on the deal. No pricing terms were disclosed.
